ClinicalTrialsFinder
RecruitingEarly Phase 1NCT05763043

Monoferric for Prenatal Iron Deficiency

Sponsor

Oregon Health and Science University

Enrollment

80 participants

Start Date

Jan 18, 2024

Study Type

INTERVENTIONAL

Conditions

Obstetric Labor Complications

Summary

A prospective observational study of pregnant women with iron deficiency anemia and oral iron intolerance or advanced gestational age.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Ferric derisomaltose for people with obstetric labor complications. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 65 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGFerric derisomaltose

Participants between the gestational ages of 14 to 42 weeks with iron deficiency will receive IV Ferric derisomaltose at a routine prenatal visit.

Locations(1)

Oregon Health & Science Univerity

Portland, Oregon, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05763043

Related Trials

The Periviable GOALS Decision Support Tool

NCT0526477912 locations

MRI Pseudo-CT Sequences for Obstetrical Pelvimetry.

NCT064853231 location

Effect of Intravenous Vitamin C on Intrapartum Maternal Fever After Epidural Labor Analgesia

NCT063545821 location

Doppler Findings in the Fetal Cerebral Blood Vessels (VA/MCA) Within 24 Hours Before Delivery and Relation With Perinatal Outcome.

NCT055991781 location

Prelabor Visual Biofeedback by a Self-operated Ultrasound Device

NCT060497841 location